Skip to main content
. 2020 Mar 20;28(6):1392–1416. doi: 10.1016/j.ymthe.2020.03.016

Table 2.

Non-mammalian Reporter Genes and Their Corresponding Imaging Tracers

Reporter

Imaging Agent
Refs.
Class Name Properties aaa Modality Properties
Enzyme β-galactosidase glycoside hydrolase enzyme; product of LacZ gene and isolated from E. coli 1,021 optical CL: near-infrared dioxetane luminophores (emission λ = 690 nm); MRI: EgadMeb; PET: 2-(4-[123I]iodophenyl)ethyl-1-thio-β-d-galactopyranoside, 3-(2′-[18F]fluoroethoxy)-2-nitrophenyl-β-d-galactopyranoside, 3-[11C]methoxy-2-nitrophenyl-β-d-galactopyranoside; [18F]FPyGal; SPECT: 5-[125I]iodoindol-3-yl-β-d-galactopyranoside ([125I]IBDG); 4-chloro-3-bromoindole-galactose (X-gal) cellular toxicity depending on the substrates; lack of sensitivity and high background; rapid renal clearance of [125I]IBDG impedes intratumoral availability if systemically administered 62, 63, 64, 65, 66, 67, 68
E. coli dihydrofolate reductase (eDHFR) catalyzes NADPH-dependent reduction of folate; inhibited by highly specific small molecule trimethoprim 159 PET: [11C]trimethoprim, [18F]trimethoprim (TMP) rapid renal clearance and hepatobiliary metabolism 69,70
HSV1-tk and mutants kinase causing cellular tracer 376 PET: [124I]FIAU, [18F]FEAU, [18F]FHBG tracers do not cross the blood-brain barrier 71, 72, 73, 74, 75
emerald luciferase (ELuc) and mutants catalyzes oxygenation of d-luciferin to oxyluciferin; emits strongest luminescence among beetle luciferases; from click beetle (Pyrearinus termitilluminans) 543 optical BL: d-luciferin/ATP (emission λ = 534–626 nm; dependent on wild-type [WT]/mutant used) lack of signal in the brain, as the substrate cannot cross the BB barrier; low thermostability and low light intensity 76, 77, 78, 79
firefly luciferase (fLuc) and mutants catalyzes the oxygenation of d-luciferin to oxyluciferin; derived from the North American firefly (Photinus pyralis) 550 optical BL: d-luciferin/ATP (emission λ = 550–615 nm; depending on WT/mutant used) depending on the type used; high thermolability and exhibits a bathochromic shift at >30°C and pH levels <7.8 80,81,82
Gaussia luciferase (GLuc) and mutants from Gaussia princeps; one of the smallest luciferases cloned so far; catalyzes the oxidative decarboxylation of coelenterazine to produce luminescence 185 optical BL: coelenterazine (emission λ = 480–513 nm; depending on WT/mutant used) no clinical use; background auto-luminescence 83, 84, 85, 86
green click beetle luciferase and mutants derived from Pyrophorus plagiophthalamus 542 optical BL: luciferin (emission λ = 543) no clinical use 87
NanoLuc derived from Oplophorus gracilorostris (deep sea shrimp) 171 optical BL: imidazopyrazinone substrate (furimazine) (emission λ = 456 nm) signal is heavily attenuated in tissues 88, 89, 90, 91
Renilla luciferase (RLuc) and mutants derived from Renilla reniformis (sea pansy) 311 optical BL: coelenterazine (emission λ = 475–535 nm; depending on the variant) WT RLuc suffers from low stability in serum and thermolability at >30°C 81,92,93
Transporter MS-1 magA putative ion transport protein from magnetotatic bacteria (Magnetospirillum sp. strain AMB-1) 434 MRI: endogenous or exogenous Fe delay of change in signal, which is dependent on Fe availability 94, 95, 96
sodium-taurocholate cotransporting polypeptide (NTCP) 349 MRI: indocyanine green (ICG) 97
Artificial protein lysine-rich protein frequency-selective contrast, based on transfer of radiofrequency labeling from the reporter’s amide protons to water protons 200 MRI: chemical exchange saturation transfer (CEST) MRI 98,99
Fluorescent proteins mNeptune fluorescent protein chromophore; derived from Entacmaea quadricolor 244 optical FL: (emission λ = 650 nm) no clinical use 100
mPlum fluorescent protein chromophore; derived from DsRed of Discosoma (sea anemone) 226 optical FL: (emission λ = 649 nm) no clinical use; low acid sensitivity 101
mTagRFP fluorescent protein chromophore; derived from Entacmaea quadricolor 238 optical FL: emission λ = 584 nm no clinical use 102
E2-Crimson derived from DsRed-Express2 225 optical FL: emission λ = 543 nm no clinical use 103,104
NIR fluorescent protein iFP1.4 requires exogenously added biliverdin as a co-factor; derived from Deinococcus radiodurans 328 optical FL: emission λ = 708 nm no clinical use 105,106
iRFP 670 endogenous biliverdin sufficient as a co-factor; derived from Rhodopseudomonas palustris (CGA009) 312 optical FL: emission λ = 670 nm no clinical use 105,107,108
iRFP 713 endogenous biliverdin sufficient as a co-factor; derived from Rhodopseudomonas palustris 317 optical FL: emission λ = 713 nm no clinical use 105,107, 108, 109
iRFP 720 endogenous biliverdin sufficient as a co-factor; derived from Rhodopseudomonas palustris 317 optical FL: emission λ = 720 nm no clinical use 110,111
Gas-filled protein complex gas vesicle structural protein A/gas vesicle protein C gas vesicles generate contrast; gas vesicles occupy more than 10% of the volume of transduced cells GvpA: 71 ultrasound: 2.7–4.7 MPa insonation 112,113
GvpA; derived from Dolichospermum lemmermannii; GvpC; derived from Dolichospermum flosaquae GvpC: 193
mammalian acoustic reporter gene (mARG) gas vesicles generate contrast 2,500 ultrasound: 3.2 MPa insonation 112

CL, chemiluminescence; BL, bioluminescence; FL, fluorescence imaging.

a

Amino acid chain length as an indication of reporter molecular weight (MW; not accounting for posttranslational modifications); wild-type reporter MWs are indicated.

b

EgadMe: 1-(2-(β-galactopyranosyloxy)propyl)-4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane)gadolinium(III).